Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


03.07.2017

1 Am J Epidemiol
1 Ann Oncol
2 Ann Surg
2 Breast Cancer (Dove Med Press)
2 Breast Cancer Res
7 Breast Cancer Res Treat
2 Cancer
2 Cancer Res
4 Clin Breast Cancer
3 Eur J Cancer
1 Int J Cancer
3 Int J Oncol
6 J Clin Oncol
1 N Engl J Med
1 Nature
14 NPJ Breast Cancer
1 Oncogene
1 Oncol Rep
5 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Epidemiol

  1. HURLEY S, Hertz A, Nelson DO, Layefsky M, et al
    Tracing a Path to the Past: Exploring the Use of Commercial Credit Reporting Data to Construct Residential Histories for Epidemiologic Studies of Environmental Exposures.
    Am J Epidemiol. 2017;185:238-246.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. OHGAMI M, Bando H, Ishiguro H, Tsuda M, et al
    Effect of dose timing on the blood concentration of lapatinib in patients with breast cancer.
    Ann Oncol. 2017 Jun 26. doi: 10.1093.
    PubMed     Text format    


    Ann Surg

  3. BOUGHEY JC, Ballman KV, McCall LM, Mittendorf EA, et al
    Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance).
    Ann Surg. 2017 Jun 27. doi: 10.1097/SLA.0000000000002373.
    PubMed     Text format     Abstract available

  4. WAKEAM E, Acuna SA, Keshavjee S
    Chest Wall Resection for Recurrent Breast Cancer in the Modern Era: A Systematic Review and Meta-analysis.
    Ann Surg. 2017 Jun 26. doi: 10.1097/SLA.0000000000002310.
    PubMed     Text format     Abstract available


    Breast Cancer (Dove Med Press)

  5. YOUSUF Z, Iman K, Iftikhar N, Mirza MU, et al
    Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer.
    Breast Cancer (Dove Med Press). 2017;9:447-459.
    PubMed     Text format     Abstract available

  6. RICE L, Goldsmith C, Green MM, Cleator S, et al
    An effective deep-inspiration breath-hold radiotherapy technique for left-breast cancer: impact of post-mastectomy treatment, nodal coverage, and dose schedule on organs at risk.
    Breast Cancer (Dove Med Press). 2017;9:437-446.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  7. POLESZCZUK J, Luddy K, Chen L, Lee JK, et al
    Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival.
    Breast Cancer Res. 2017;19:75.
    PubMed     Text format     Abstract available

  8. MORRISON JOLY M, Williams MM, Hicks DJ, Jones B, et al
    Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Breast Cancer Res. 2017;19:74.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  9. MAXWELL KN, Soucier-Ernst D, Tahirovic E, Troxel AB, et al
    Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.
    Breast Cancer Res Treat. 2017 Jun 26. doi: 10.1007/s10549-017-4339.
    PubMed     Text format    

  10. CHIEN AJ, Chambers J, Mcauley F, Kaplan T, et al
    Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
    Breast Cancer Res Treat. 2017 Jun 28. doi: 10.1007/s10549-017-4350.
    PubMed     Text format    

  11. BLUETHMANN SM, Alfano CM, Clapp JD, Luta G, et al
    Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).
    Breast Cancer Res Treat. 2017 Jun 26. doi: 10.1007/s10549-017-4353.
    PubMed     Text format     Abstract available

  12. ABDEL-RAZEQ H, Marei L, Saadeh SS, Abdulelah H, et al
    From clinical trials to clinical practice: outcome of NSABP-B27 neoadjuvant chemotherapy regimen for high-risk early-stage breast cancer.
    Breast Cancer Res Treat. 2017 Jun 30. doi: 10.1007/s10549-017-4359.
    PubMed     Text format     Abstract available

  13. VERHEUVEL NC, Voogd AC, Tjan-Heijnen VCG, Siesling S, et al
    Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure.
    Breast Cancer Res Treat. 2017 Jun 27. doi: 10.1007/s10549-017-4342.
    PubMed     Text format     Abstract available

  14. YANG XR, Devi BCR, Sung H, Guida J, et al
    Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.
    Breast Cancer Res Treat. 2017 Jun 29. doi: 10.1007/s10549-017-4356.
    PubMed     Text format     Abstract available

  15. NITZ U, Gluz O, Christgen M, Kates RE, et al
    Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
    Breast Cancer Res Treat. 2017 Jun 29. doi: 10.1007/s10549-017-4358.
    PubMed     Text format     Abstract available


    Cancer

  16. TARAZI WW, Bradley CJ, Bear HD, Harless DW, et al
    Impact of Medicaid disenrollment in Tennessee on breast cancer stage at diagnosis and treatment.
    Cancer. 2017 Jun 26. doi: 10.1002/cncr.30771.
    PubMed     Text format     Abstract available

  17. SUBRAMANIAN S, Keating NL
    Delays in breast cancer diagnosis after a state policy limiting Medicaid enrollment.
    Cancer. 2017 Jun 26. doi: 10.1002/cncr.30769.
    PubMed     Text format    


    Cancer Res

  18. YOU E, Huh YH, Kwon A, Kim SH, et al
    SPIN90 depletion and Microtubule Acetylation Mediate Stromal Fibroblast Activation in Breast Cancer Progression.
    Cancer Res. 2017 Jun 26. pii: canres.0657.2017.
    PubMed     Text format     Abstract available

  19. SALEH SM, Bertos NR, Gruosso T, Gigoux M, et al
    Identification of interacting stromal axes in triple-negative breast cancer.
    Cancer Res. 2017 Jun 26. pii: canres.3427.2016.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  20. ROBERT NJ, Denduluri N
    Patient Case Lessons: Endocrine Management of Advanced Breast Cancer.
    Clin Breast Cancer. 2017 Jun 7. pii: S1526-8209(16)30502.
    PubMed     Text format     Abstract available

  21. BIGLIA N, Bounous VE, D'Alonzo M, Ottino L, et al
    Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists.
    Clin Breast Cancer. 2017 May 19. pii: S1526-8209(17)30095.
    PubMed     Text format     Abstract available

  22. CHO YT, Su H, Chiang YY, Shiea J, et al
    Fine Needle Aspiration Combined With Matrix-assisted Laser Desorption Ionization Time-of-Flight/Mass Spectrometry to Characterize Lipid Biomarkers for Diagnosing Accuracy of Breast Cancer.
    Clin Breast Cancer. 2017 May 25. pii: S1526-8209(16)30538.
    PubMed     Text format     Abstract available

  23. STEGER GG, Dominguez A, Dobrovolskaya N, Giotta F, et al
    Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study.
    Clin Breast Cancer. 2017 Jun 27. pii: S1526-8209(16)30562.
    PubMed     Text format     Abstract available


    Eur J Cancer

  24. HONG N, Yoon HG, Seo DH, Park S, et al
    Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.
    Eur J Cancer. 2017;82:103-114.
    PubMed     Text format     Abstract available

  25. SAGUATTI G, Naldoni C, Benelli E, Fedato C, et al
    Letter to the Editor regarding the paper by F. Cardoso et al. 'European Breast Cancer Conference manifesto on breast centres/units'.
    Eur J Cancer. 2017 Jun 26. pii: S0959-8049(17)31004.
    PubMed     Text format    

  26. PIVOT X, Spano JP, Espie M, Cottu P, et al
    Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study.
    Eur J Cancer. 2017 Jun 22. pii: S0959-8049(17)30960.
    PubMed     Text format     Abstract available


    Int J Cancer

  27. FELLER A, Schmidlin K, Bordoni A, Bouchardy C, et al
    Socioeconomic and demographic disparities in breast cancer stage at presentation and survival: A Swiss population-based study.
    Int J Cancer. 2017 Jun 28. doi: 10.1002/ijc.30856.
    PubMed     Text format     Abstract available


    Int J Oncol

  28. KIM DH, Sung B, Kim JA, Kang YJ, et al
    HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.
    Int J Oncol. 2017 Jun 27. doi: 10.3892/ijo.2017.4058.
    PubMed     Text format     Abstract available

  29. NOWAK A, Grzegrzolka J, Paprocka M, Piotrowska A, et al
    Nestin-positive microvessel density is an independent prognostic factor in breast cancer.
    Int J Oncol. 2017 Jun 26. doi: 10.3892/ijo.2017.4057.
    PubMed     Text format     Abstract available

  30. YAO M, Yuan B, Wang X, Sato A, et al
    Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7.
    Int J Oncol. 2017 Jun 23. doi: 10.3892/ijo.2017.4052.
    PubMed     Text format     Abstract available


    J Clin Oncol

  31. POWLES TJ, Paterson AHG, Gralow JR
    Optimal Use of Adjuvant Bisphosphonates and Breast Cancer.
    J Clin Oncol. 2017 Jun 27:JCO2017736157. doi: 10.1200/JCO.2017.73.6157.
    PubMed     Text format    

  32. CHLEBOWSKI RT, Aragaki AK, Anderson GL, Thomson CA, et al
    Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial.
    J Clin Oncol. 2017 Jun 27:JCO2016720326. doi: 10.1200/JCO.2016.72.0326.
    PubMed     Text format     Abstract available

  33. SAHA P, Regan MM, Pagani O, Francis PA, et al
    Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.
    J Clin Oncol. 2017 Jun 27:JCO2016720946. doi: 10.1200/JCO.2016.72.0946.
    PubMed     Text format     Abstract available

  34. SMITH SG, Sestak I, Howell A, Forbes J, et al
    Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I).
    J Clin Oncol. 2017 Jun 29:JCO2016717439. doi: 10.1200/JCO.2016.71.7439.
    PubMed     Text format     Abstract available

  35. EJLERTSEN B, Tuxen MK, Jakobsen EH, Jensen MB, et al
    Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial.
    J Clin Oncol. 2017 Jun 29:JCO2017723494. doi: 10.1200/JCO.2017.72.3494.
    PubMed     Text format     Abstract available

  36. CURIGLIANO G, Criscitiello C
    Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    J Clin Oncol. 2017 Jun 29:JCO2017725960. doi: 10.1200/JCO.2017.72.5960.
    PubMed     Text format     Abstract available


    N Engl J Med

  37. LANNIN DR, Wang S
    Are Small Breast Cancers Good because They Are Small or Small because They Are Good?
    N Engl J Med. 2017;376:2286-91.
    PubMed     Text format    


    Nature

  38. RHEINBAY E, Parasuraman P, Grimsby J, Tiao G, et al
    Recurrent and functional regulatory mutations in breast cancer.
    Nature. 2017 Jun 28. doi: 10.1038/nature22992.
    PubMed     Text format     Abstract available


    NPJ Breast Cancer

  39. SOLZAK JP, Atale RV, Hancock BA, Sinn AL, et al
    Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer.
    NPJ Breast Cancer. 2017;3:17.
    PubMed     Text format     Abstract available

  40. VAYSSE C, Lomo J, Garred O, Fjeldheim F, et al
    Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer.
    NPJ Breast Cancer. 2017;3:19.
    PubMed     Text format     Abstract available

  41. CREW KD, Albain KS, Hershman DL, Unger JM, et al
    How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
    NPJ Breast Cancer. 2017;3:20.
    PubMed     Text format     Abstract available

  42. NASSER NJ, Fenig S, Ravid A, Nouriel A, et al
    Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients.
    NPJ Breast Cancer. 2017;3:10.
    PubMed     Text format     Abstract available

  43. BOWER JJ, Vance LD, Psioda M, Smith-Roe SL, et al
    Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells.
    NPJ Breast Cancer. 2017;3:9.
    PubMed     Text format     Abstract available

  44. ADAMS S
    Dramatic response of metaplastic breast cancer to chemo-immunotherapy.
    NPJ Breast Cancer. 2017;3:8.
    PubMed     Text format     Abstract available

  45. CHUNG B, Esmaeili AA, Gopalakrishna-Pillai S, Murad JP, et al
    Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12.
    NPJ Breast Cancer. 2017;3:6.
    PubMed     Text format     Abstract available

  46. TEUGELS E, De Brakeleer S
    An alternative model for (breast) cancer predisposition.
    NPJ Breast Cancer. 2017;3:13.
    PubMed     Text format     Abstract available

  47. SLAVIN TP, Maxwell KN, Lilyquist J, Vijai J, et al
    The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
    NPJ Breast Cancer. 2017;3:22.
    PubMed     Text format     Abstract available

  48. KIM Y, McCarthy AM, Bristol M, Armstrong K, et al
    Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer.
    NPJ Breast Cancer. 2017;3:2.
    PubMed     Text format     Abstract available

  49. MURPHY ME, Liu S, Yao S, Huo D, et al
    A functionally significant SNP in TP53 and breast cancer risk in African-American women.
    NPJ Breast Cancer. 2017;3:5.
    PubMed     Text format     Abstract available

  50. PIVOT X, Romieu G, Fumoleau P, Rios M, et al
    Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.
    NPJ Breast Cancer. 2017;3:4.
    PubMed     Text format     Abstract available

  51. BAYANI J, Yao CQ, Quintayo MA, Yan F, et al
    Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine.
    NPJ Breast Cancer. 2017;3:3.
    PubMed     Text format     Abstract available

  52. JOLLY MK, Boareto M, Debeb BG, Aceto N, et al
    Inflammatory breast cancer: a model for investigating cluster-based dissemination.
    NPJ Breast Cancer. 2017;3:21.
    PubMed     Text format     Abstract available


    Oncogene

  53. HERNANDEZ-PEREZ S, Cabrera E, Salido E, Lim M, et al
    DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  54. SEO HS, Ku JM, Choi HS, Woo JK, et al
    Apigenin overcomes drug resistance by blocking the signal transducer and activator of transcription 3 signaling in breast cancer cells.
    Oncol Rep. 2017 Jun 26. doi: 10.3892/or.2017.5752.
    PubMed     Text format     Abstract available


    PLoS One

  55. AMARA S, Majors C, Roy B, Hill S, et al
    Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation.
    PLoS One. 2017;12:e0180097.
    PubMed     Text format     Abstract available

  56. JEONG J, Park S, An HT, Kang M, et al
    Small leucine zipper protein functions as a negative regulator of estrogen receptor alpha in breast cancer.
    PLoS One. 2017;12:e0180197.
    PubMed     Text format     Abstract available

  57. TAMURA M, Sugiura S, Takagi T, Satoh T, et al
    Morphology-based optical separation of subpopulations from a heterogeneous murine breast cancer cell line.
    PLoS One. 2017;12:e0179372.
    PubMed     Text format     Abstract available

  58. BJORGE JD, Pang A, Fujita DJ
    Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release.
    PLoS One. 2017;12:e0180578.
    PubMed     Text format     Abstract available

  59. SKOOG P, Ohlsson M, Ferno M, Ryden L, et al
    Tumor tissue protein signatures reflect histological grade of breast cancer.
    PLoS One. 2017;12:e0179775.
    PubMed     Text format     Abstract available


    Radiology

  60. LEE-FELKER SA, Tekchandani L, Thomas M, Gupta E, et al
    Newly Diagnosed Breast Cancer: Comparison of Contrast-enhanced Spectral Mammography and Breast MR Imaging in the Evaluation of Extent of Disease.
    Radiology. 2017 Jun 26:161592. doi: 10.1148/radiol.2017161592.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: